Hematopoietic Stem Cell TransplantationPeripheral Blood Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousGraft vs Host DiseaseTransplantation ConditioningBone Marrow TransplantationHematopoietic Stem CellsStem CellsHematopoietic Stem Cell MobilizationStem Cell TransplantationHematologic NeoplasmsGranulocyte Colony-Stimulating FactorLeukapheresisAntigens, CD34Treatment OutcomeImmunosuppressive AgentsTissue DonorsTransplantationBlood Component RemovalHistocompatibility TestingGraft SurvivalImmunocompromised HostHematopoiesisMelphalanMyeloid CellsCombined Modality TherapyStem Cell NicheTransplantation ChimeraMultiple MyelomaCyclophosphamideLeukemiaBusulfanCell DifferentiationCytomegalovirus InfectionsAdult Stem CellsRetrospective StudiesAntineoplastic Combined Chemotherapy ProtocolsCord Blood Stem Cell TransplantationHistocompatibilityRecurrenceHepatic Veno-Occlusive DiseaseEmbryonic Stem CellsAnemia, AplasticFlow CytometryBone Marrow CellsOpportunistic InfectionsMyeloablative AgonistsBone MarrowLymphoma, Non-HodgkinBlood CellsWhole-Body IrradiationTime FactorsCell LineageColony-Forming Units AssayFetal BloodCells, CulturedBlood Cell CountRemission InductionHLA AntigensMice, Inbred C57BLSalvage TherapyPluripotent Stem CellsEtoposideSurvival RateFollow-Up StudiesPancytopeniaHematologic DiseasesBone Marrow PurgingBlood DonorsAntineoplastic Agents, AlkylatingSurvival AnalysisCytomegalovirusInfectionDisease-Free SurvivalThiotepaVidarabineLeukemia, Myeloid, AcuteAntifungal AgentsKidney TransplantationNeoplasmsStem Cell FactorMycosesHodgkin DiseaseFatal OutcomeCell SeparationCell CountNeural Stem CellsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveAspergillosisInduced Pluripotent Stem CellsMesenchymal Stem Cell TransplantationCell ProliferationCyclosporineRoseolovirus InfectionsLeukocyte TransfusionLymphocyte DepletionAcute DiseaseTransplantsAmyloidosis